Umami Bioworks key facts
as of Oct 2026- Producer of cell-based food products intended to offer a healthy alternative to seafood.
- Umami Bioworks is valued at approximately $63.6M as of Oct 2026 (last reported valuation).
- It has raised $34.1M; the latest was Later Stage VC in Feb 2026.
- Notable investors include Plug and Play Tech Center, Y Combinator, Creative Destruction Lab, MassChallenge, Entrepreneurs First — 42 tracked in total.
- Status: Privately Held (backing).
Umami Bioworks's last reported valuation, Sep 2024. Nothing priced has surfaced since.
- ·The complete investor list: 42 names
- ·Watch Umami Bioworks: the Monday email on marks, rounds and moves
Umami Bioworks funding rounds
No funding rounds for Umami Bioworks are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Umami Bioworks
42+Membership and data by Private Market View
Umami Bioworks valuation
Umami Bioworks's last reported valuation was $63.6 million in Sep 2024. No priced round, secondary trade or fund mark has surfaced since.
Umami Bioworks investors
42 investors are on record for Umami Bioworks, including Plug and Play Tech Center, Y Combinator, Creative Destruction Lab and MassChallenge. By type, the record holds 8 venture capital firms and 1 family office.
About Umami Bioworks
Producer of cell-based food products intended to offer a healthy alternative to seafood. The company's products are directly made from fish cells and tissue and are free from mercury, antibiotics, microplastics, and ocean pollutants, enabling customers to find affordable, cell-cultured seafood and meat with low-cost, serum-free media and novel marine cell lines.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Singapore, Singapore
- Founded
- 2020
- Employees
- 40
- Website
- umamibioworks.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.